| Full Name | Kelatess Pc |
|---|---|
| Speciality | Psychologist |
| Location | 1441 E Maple Ave, Burton, Michigan |
| Authorized Official Name and Position | Matthew P. Dickson (PRESIDENT) |
| Authorized Official Contact | 8106061099 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Kelatess Pc 7382 Mohansic Dr Bloomfield Hills MI 48301-3552 Ph: (810) 606-1099 | Kelatess Pc 1441 E Maple Ave Burton MI 48529-2059 Ph: (810) 820-6265 |
| NPI Number | 1659305860 |
|---|---|
| Provider Enumeration Date | 07/11/2006 |
| Last Update Date | 11/30/2016 |
| Medicare PECOS PAC ID | 0648240895 |
|---|---|
| Medicare Enrollment ID | O20040727000770 |
News Archive
YM BioSciences Inc., is presenting posters on its JAK1/2 inhibiting small molecule (CYT387) and on its novel vascular disrupting agent (CYT997) at the Lorne Cancer Conference in Lorne, Victoria, Australia. CYT387 is an oral JAK1/2 inhibitor, originating from the seminal discovery of JAK1 and JAK2 kinases by Dr. Andrew Wilks, the founder of Cytopia Limited, now YM Australia. CYT997 is an orally-available agent with dual mechanisms of vascular disruption and cytotoxicity and has the potential to be broadly active against a range of tumor types.
M*Modal, a leading provider of clinical documentation services and Speech Understanding technologies, today announced that Duke University Health System (DUHS) has selected the Company's cloud-based Speech Understanding technology to support the rollout of its Epic electronic health record.
A recent study investigates the paradoxical effects of dosage and dosing interval on COVID-19 vaccine efficacy.
Pulsatile gonadotropin-releasing hormone may be more effective than human chorionic gonadotropin for the treatment of peripubescent boys with hypogonadotropic hypogonadodism, say Chinese researchers.
"The world's anti-poverty gains achieved over the past years are being eroded by the presence of multiple crises, including an unprecedented economic and financial crisis, increased food [in]security, oil prices volatility and climate change," according to a report released Monday by U.N. Secretary-General Ban Ki-moon during the opening of an annual high-level segment of the U.N. Economic and Social Council (ECOSOC), Bernama reports.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659305860 | NPI | - | NPPES |
| 680F33159 | Other | MI | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 6301006835 (Michigan) | Primary |
| Provider Name | Matthew P Dickson |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1437321502 PECOS PAC ID: 9234109497 Enrollment ID: I20040727001046 |
News Archive
YM BioSciences Inc., is presenting posters on its JAK1/2 inhibiting small molecule (CYT387) and on its novel vascular disrupting agent (CYT997) at the Lorne Cancer Conference in Lorne, Victoria, Australia. CYT387 is an oral JAK1/2 inhibitor, originating from the seminal discovery of JAK1 and JAK2 kinases by Dr. Andrew Wilks, the founder of Cytopia Limited, now YM Australia. CYT997 is an orally-available agent with dual mechanisms of vascular disruption and cytotoxicity and has the potential to be broadly active against a range of tumor types.
M*Modal, a leading provider of clinical documentation services and Speech Understanding technologies, today announced that Duke University Health System (DUHS) has selected the Company's cloud-based Speech Understanding technology to support the rollout of its Epic electronic health record.
A recent study investigates the paradoxical effects of dosage and dosing interval on COVID-19 vaccine efficacy.
Pulsatile gonadotropin-releasing hormone may be more effective than human chorionic gonadotropin for the treatment of peripubescent boys with hypogonadotropic hypogonadodism, say Chinese researchers.
"The world's anti-poverty gains achieved over the past years are being eroded by the presence of multiple crises, including an unprecedented economic and financial crisis, increased food [in]security, oil prices volatility and climate change," according to a report released Monday by U.N. Secretary-General Ban Ki-moon during the opening of an annual high-level segment of the U.N. Economic and Social Council (ECOSOC), Bernama reports.
› Verified 4 days ago
News Archive
YM BioSciences Inc., is presenting posters on its JAK1/2 inhibiting small molecule (CYT387) and on its novel vascular disrupting agent (CYT997) at the Lorne Cancer Conference in Lorne, Victoria, Australia. CYT387 is an oral JAK1/2 inhibitor, originating from the seminal discovery of JAK1 and JAK2 kinases by Dr. Andrew Wilks, the founder of Cytopia Limited, now YM Australia. CYT997 is an orally-available agent with dual mechanisms of vascular disruption and cytotoxicity and has the potential to be broadly active against a range of tumor types.
M*Modal, a leading provider of clinical documentation services and Speech Understanding technologies, today announced that Duke University Health System (DUHS) has selected the Company's cloud-based Speech Understanding technology to support the rollout of its Epic electronic health record.
A recent study investigates the paradoxical effects of dosage and dosing interval on COVID-19 vaccine efficacy.
Pulsatile gonadotropin-releasing hormone may be more effective than human chorionic gonadotropin for the treatment of peripubescent boys with hypogonadotropic hypogonadodism, say Chinese researchers.
"The world's anti-poverty gains achieved over the past years are being eroded by the presence of multiple crises, including an unprecedented economic and financial crisis, increased food [in]security, oil prices volatility and climate change," according to a report released Monday by U.N. Secretary-General Ban Ki-moon during the opening of an annual high-level segment of the U.N. Economic and Social Council (ECOSOC), Bernama reports.
› Verified 4 days ago
Better Odds Behavioral Health, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5515 Davison Rd Ste 9, Burton, MI 48509 Phone: 810-429-2959 | |
Strive Center For Autism Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: G4476 S. Dort Hwy, Burton, MI 48529 Phone: 810-344-8082 Fax: 810-222-0279 | |
Mccrandall Therapy Services Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2394 Willowdale Dr, Burton, MI 48509 Phone: 810-373-2867 | |
Senior Therapeutic Solutions, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4001 Walli Strasse Dr Ste B, Burton, MI 48509 Phone: 810-306-2858 | |
Alternatives For Children & Families, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: G2065 S Center Rd, Burton, MI 48519 Phone: 810-250-3800 Fax: 810-250-3836 | |
Genesee Health System Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1513 S Center Rd, Burton, MI 48509 Phone: 810-496-5543 | |
Healing Connexion, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6141 Woodmoor Dr, Burton, MI 48509 Phone: 810-964-5481 |